Objective: Although an important quality metric, current technical performance scores may not be generalizable and may omit operative factors that influence outcomes. We examined factors not included in current technical performance scores that may contribute to increased postoperative length of stay, major complications, and cost after primary repair of tetralogy of Fallot.
Methods: This is a retrospective single site study of patients younger than age 2 years with tetralogy of Fallot undergoing complete repair between 2007 and 2015. Medical record data and discharge echocardiograms were reviewed to ascertain component and composite technical performance scores. Primary outcomes included postoperative length of stay, major complications, and total hospital costs. Multivariable logistic and linear regression identified determinants of each outcome.
Results: Patient population (n ¼ 115) had a median postoperative length of stay of 8 days (interquartile range, 6-10 days), and a median total cost of $71,147. Major complications occurred in 33 patients (29%) with 1 death. Technical performance scores assigned were optimum in 28 patients (25%), adequate in 59 patients (52%), and inadequate in 26 patients (23%). Neither technical performance score components nor composite scores were associated with increased postoperative length of stay. Optimum or adequate repairs versus inadequate had equal risk of a complication (P ¼ .79), and equivalent mean total cost ($100,000 vs $187,000; P ¼ .25). Longer cardiopulmonary bypass time per 1-minute increase (P<.01) was associated with longer postoperative length of stay and reintervention (P ¼ .02). The need to return to bypass also increased total cost (P <.01).
Conclusions: Current tetralogy of Fallot technical performance scores were not associated with selected outcomes in our postoperative population. Although returning to bypass and bypass length are not included as components in the current score, these are important factors influencing complications and resource use in our population. Revisions anticipated from a prospective trial should consider including these variables. (J Thorac Cardiovasc Surg 2017;154:585-95) Percent of tetralogy of Fallot cases with reintervention during index hospitalization after repair stratified by cardiopulmonary bypass time and crossclamp time.
Central Message
Important factors that influence patient outcomes are not included in the current technical performance scores for tetralogy of Fallot repair.
Perspective
This study demonstrates that currently available technical performance scores for tetralogy of Fallot may lack generalizability. Specific operative characteristics, such as the length of cardiopulmonary bypass and crossclamp times, and the need to return to bypass, although resulting in the same reported score, influence clinical outcomes differently.
See Editorial Commentary page 596.
Tetralogy of Fallot (TOF) is among the benchmark operations in congenital heart surgery, with excellent short-and long-term contemporary outcomes. 1 Surgical repair has evolved from an initial strategy of complete relief of right ventricular outflow tract obstruction (RVOTO) with consequent free pulmonary insufficiency to a strategy of valve-preservation and permissive mild pulmonary valvular stenosis. A technical performance score (TPS) for the subdomains of TOF repair, as originally described by Larrazabal and colleagues in 2007, 2 has likewise evolved. The original lexicon specified no residual stenosis as optimal and any mild residual gradient of 40 mm Hg as adequate. Subsequent iterations of the TPS for the subdomains of RVOTO specified an optimal repair as a gradient < 2.2 m/s across the subpulmonary area and a gradient or < 2.0 m/s across the pulmonary valve itself. 3, 4 The original description of an optimum status of the right ventricular outflow tract (RVOT) following correction, therefore, may not actually reflect the best physiologic repair. Moreover, whereas the TPS represents an important metric to objectively assess the quality of surgical repairs and has been correlated with specific short-term outcomes, our group, 5 and others, 6 have commented on the limitations of the current TPS. One of these critical assumptions is the premise that the final result (ie, TPS composite score) is equivalent regardless of the amount of time necessary to achieve it or the number of tries necessary. Indeed, the recently launched Pediatric Heart Network-sponsored Residual Lesions Trial endeavors to address many of these shortcomings.
The objectives of this study, therefore, were to determine whether the currently available TPS for TOF are associated with purported clinical outcomes, including reintervention, morbidity, and cost (ie, determine generalizability with the current score) in infants undergoing complete repair of TOF and to determine whether there are additional intraoperative factors not currently captured by the TPS that are associated with these same outcomes (we specifically focused on cardiopulmonary bypass (CPB) time and number of CPB runs based on a priori assumptions).
METHODS Data Source, Patient Population, and Data Collection
This retrospective study from the University of California, San Francisco, used single-site patient records between January 2007 and June 2015. Institutional records and Society of Thoracic Surgeons Congenital Heart Surgery Database were concurrently scanned for consecutive patients with a diagnosis of TOF undergoing surgical primary repair before age 2 years. An estimated 268 TOF interventions were initially found that included reintervention, additional repairs, and prerepair palliative interventions such as the modified Blalock-Tausig shunt, ductal stent, pulmonary valvotomy, or RVOT stent. Patients diagnosed with a variation of TOF, such as pentalogy of Cantrell, TOF with pulmonary atresia and multiple aortopulmonary collaterals, and complete atrioventricular canal were excluded from this study. However, those with tetralogy-type double-outlet right ventricle (DORV) were included, given that these patients are anatomically similar to those with TOF and there were no obvious differences in patient characteristics between these patients and the entire population. Patients undergoing right ventricle-pulmonary artery conduits were included given that the patients within this category were not those with severely hypoplastic branch pulmonary arteries and/or major aortopulmonary collateral arteries, and underwent otherwise similar repairs. Right ventricle-pulmonary artery conduits were implanted in the following 2 conditions: in patients with valvular stenosis that prohibited a valve-sparing approach or a nontransannular incision in the presence of important crossing coronary branches and patients with pulmonary atresia. This left 115 patients available for study, 113 of whom had full echocardiographic review. Preoperative, intraoperative, and discharge echocardiograms were reviewed by 2 pediatric cardiologists (S.S. and K.H.) with oversight by 2 experienced pediatric echocardiologists (S.P. and A.M.G.), with specific attention to the anatomic components needed to construct TPS scores. Only the discharge echocardiograms and in-hospital reinterventions were used to determine the component TPS scores and the final score as described by Larrazabal and colleagues. 2 Updated TPS criteria proposed by Nathan and colleagues 3 were also incorporated, for comparison. Appropriate anatomic factors were converted to z scores, using the Boston Children's Hospital z score algorithm for calculating z scores by patient body surface area, height, and weight. 7 Specific repair techniques and strategies were at the discretion of the surgeon and the referring cardiologist, with input from a multidisciplinary care team.
Outcomes of Interest and Study Variables
Our primary outcomes of interest were postoperative length of stay, reintervention during hospitalization, and hospital cost. Additional bypass runs were not considered additional reinterventions. We also examined in-hospital mortality and the prevalence of the 6 major complications, as defined by the Society of Thoracic Surgeons Congenital Heart Surgery Database. 8 The 6 major complications include renal failure requiring temporary or permanent dialysis, neurologic deficit persisting at discharge, atrioventricular block, or arrhythmia requiring a permanent pacemaker, postoperative mechanical circulatory support, phrenic nerve injury, or any unplanned reintervention before discharge. Total cost was calculated summing the direct cost (the cost of services rendered during each patient's hospitalization) and the indirect cost (expenses that cannot be directly associated with patient care, such as hospital utilities, security, and administrative fees). Indirect costs were computed using an algorithm to calculate variable and fixed indirect costs. 9 Values were adjusted for inflation using Bureau of Labor Statistics US Consumer Price Index for Medical-Cost inflation.
10 Total costs were considered with and without statistical outliers, and total costs were also related to the length of stay to determine cost per day (total cost divided by total length of stay). Patient insurance status was also included in this study. Multivariable regression analysis identified variables associated with each of our outcomes and the influence of confounders. Sex, weight at repair, and age of repair were all included to produce models adjusted for patient characteristics. Certain predictor variables, such as CPB time, were dichotomized at the mean or median value, but were also considered as continuous factors in all multivariable analysis. Component TPS scores, in addition to the final composite TPS score, were considered as variables in all multivariable models.
Data Analysis
A list of candidate variables tested for the multivariable analysis is shown in Table E1 .
Selection methods for multivariable models were chosen to optimize model performance using receiver-operating characteristics curve analysis. Linear regression was used for postoperative length of stay (POLOS), whereas logistic regression was used for the occurrence of each individual complication, with special emphasis on reintervention. Additionally, Poisson regression was used to examine factors associated with the number of these events, given the ordinal nature of this variable. All regression analyses were completed with a ¼ 0.10 and with mean imputation for any missing values. Results were aggregated using Microsoft Excel (Microsoft Corporation, Redmond, Wash) and statistical analysis was completed with SAS version 9.3 (SAS Institute, Cary, NC).
Permission to conduct the study was obtained by the University of California, San Francisco, institutional review board under expedited review for existing data and need for patient consent was waived.
RESULTS

TPS Calculation and Associations With Selected Outcomes
Descriptive characteristics are shown in Tables 1 and 2 . TPS assessment of our cohort (calculated from 113 patients with complete echo data) found no patients that could be categorized as optimal based on the criteria originally described by Larrazabal and colleagues 2 (Table E2 ). There were no optimum repairs owing to the gradient > 0 across either the pulmonary valve or the subpulmonary area. The majority of cases were categorized as having adequate repairs (87 out of 113; 77%) and a minority was scored inadequate (26 out of 113; 23%). However, when constructing the TPS score based on the updated criteria, 28 repairs (25%) were scored optimum, 59 repairs (52%) were scored adequate, and 26 repairs (23%) were scored inadequate (Table E3 ). Repairs scored as either optimum or adequate versus inadequate had equal risk of having 1 or more major 
Univariable Factors and Their Relationship to Outcomes
Several patient and intraoperative characteristics influenced the risk of in-hospital reintervention (Table 3) and POLOS. Greater than average CPB time (P ¼ .03) and crossclamp time (P ¼ .03) were significantly associated with reintervention ( Figure 1 ). Univariable analysis of surgical techniques and patient characteristics versus mean POLOS are depicted in Figure E1 . Two risk factors were significantly associated with shorter POLOS: intraoperative chest closure (9.1 vs 18.6 days POLOS; P <.01) and age greater than or equal to the mean age of 129 days (7.9 vs 11.6 days POLOS; P ¼ .04). Total costs analyses are shown in Table 4 . When removing 3 outliers, in whom the costs were > $500,000 (new mean, $91,775 AE $59,074), nonvalve-sparing procedures (101,000 vs $77,000; P ¼ .03) had an increased total cost. In-hospital cost per day tended to be increased in patients with longer crossclamp times ($8803 vs $8113; P ¼ .07), in patients with supravalvular obstruction in addition to either valvular or subvalvular obstruction ($9115 vs $8241; P ¼ .05), those with trisomy 21 ($10,073 vs $8402; P ¼ .05), and those with commercial insurance versus MediCal ($8954 vs $7473; P <.01).
Multivariable Factors Associated With Outcomes
Several patient characteristics such as nonvalvular obstruction (P ¼ .05), having other noncardiac comorbidities (P ¼ .07), and DORV-variant (P ¼ .07) were all associated with increased POLOS. Regarding operative factors, longer CPB time (b ¼ 0.1 [per minute]; P <.01), delayed sternal closure (b ¼ À8.3; P < .01), and polyethylene terephthalate ventricular septal defect (VSD) patch material versus CorMatrix (Roswell, Ga) (b ¼ 11.9; P<.01) were all associated with a longer POLOS (Table 5) . No TPS subcategory or score was associated with increased POLOS.
Regarding the prevalence of in-hospital complications, specific operative characteristics, including longer aortic crossclamp duration (P ¼ .02) and synthetic patch material for RVOTO reconstruction (P ¼ .02) were associated with an increase risk of a complication, after adjustment for patient and anatomic factors (Table E4) . Risk factors for mortality were not sought owing to the fact that there was only 1 death.
Factors associated with an increased total cost are shown in Table 4 . Return to CPB to address a residual or additional VSD was associated with increased total cost (P < .01). 
CONG
None of the component nor composite TPS scores was associated with in-hospital cost.
DISCUSSION
We have described the utility of the originally proposed TPS insofar as its relationship to multiple in-hospital outcomes in our single-institution series. We found that neither the component scores nor the composite TPS score were associated with POLOS, total cost, complications, or reintervention in our population. However, our data demonstrate that increased CPB and aortic crossclamp duration, as well as additional bypass runs, none of which are included in either the initial or updated TPS criteria, are important factors influencing both the prevalence of complications and resource use. CPB times and aortic crossclamp times have been correlated with nearly every outcome examined in cardiac surgery. [11] [12] [13] [14] A recent article by Chalmers and colleagues 15 demonstrated that increased CPB time was associated with mortality and longer PO-LOS. Increased crossclamp times are commonly used to assess technical proficiency. 15 Related surgical disciplines use operative time in a parallel fashion, and decreases in task time are often used to demonstrate improved learner skill and proficiency. 16, 17 Moreover, Jolley and colleagues 18 have shown that increased operative times, which were found in cases performed by less-experienced surgeons, increased resource use. The authors stated in their conclusion, ''Resident operations do appear to have real consequences for patients and may impact the healthcare system financially.'' 18 Clearly the end result of an operation (ie, the composite TPS) is important, but our results would support the contention that the time it takes to achieve a given result and the number of tries necessary should also be considered. Unfortunately, given the limited number of surgeons in this series, we were unable to look at the influence of surgeon experience on outcome, but would expect that there would be an inverse relationship, as demonstrated in prior studies.
Our results demonstrating a lack of association between the current TPS and selected outcomes for our TOF population are in contrast to a study by Nathan and colleagues 3 specifically examining reintervention in TOF patients undergoing valve-sparing repair. Several other manuscripts from the same group [19] [20] [21] also found significant associations between TPS and both short-term and longterm outcomes in a heterogeneous group of postrepair congenital heart disease patients. Although the TOF article by Nathan and colleagues 3 identified TPS as a predictor for reintervention and POLOS, other surgical characteristics that could have affected these outcomes were not considered. Importantly, the finding that pulmonary valve z score was highly correlated with optimum TPS score in the study by Nathan and colleagues 3 may indicate that an optimum repair surrogates an anatomic subtype (larger pulmonary valve z score), and that it is this anatomic subtype rather than the TPS score that predicts reintervention. Unfortunately, multivariable analysis to ascertain those variables with the best predictive value regarding outcome was not presented in this article.
There are important differences between our patient population and those investigated in prior publications that may have influenced our findings. In the study by Nathan and colleagues, 3 which looked at those receiving valvesparing approaches, the distribution of scores was 22% optimum, 70% adequate, and 8% inadequate, whereas in our study, there were 25% optimum, 52% adequate, and 23% inadequate. Although the median age at repair was similar in both series (105 days and 109 days), we included patients throughout the spectrum of TOF (including DORV), and this may have contributed to this differential. The results of our present study are important because they illustrate that current TPS scoring algorithms (whether initial or updated) may not be generalizable to all centers. Moreover, given the widespread use of scoring systems, it would be important to define (or describe) patient populations (or centers) in which current scores may perform less reliably. Variation in pediatric surgical outcomes is well described in our field 22 and it is critical to understand whether our available tools perform equally across the spectrum.
Clearly there have been improvements made to the initial TPS criteria. We used both the initial iteration of the 2007 score, as well as the updated TPS score, to capture these modifications. Using the initial criteria that specify no stenosis across either the RVOT or the pulmonary valve is considered optimal, we found that 25 repairs would be considered adequate rather than optimum due to having a gradient 20 mm Hg. The originally published criteria, therefore, seem at odds with the contemporary notion that pulmonary valve preservation with mild stenosis is preferable to free pulmonary insufficiency. Supportive of this concept, patients who underwent valve-sparing TOF repair in the present study had both a decrease in total cost and shorter POLOS. Patients amenable to valvesparing approaches may represent a population with lesssevere forms of tetralogy, could enjoy improved postrepair physiology from the avoidance of free pulmonary insufficiency, or may also have avoided prerepair palliation. Several studies have found that patients who receive valve-sparing procedures have better perioperative outcomes and shorter POLOS. 23, 24 Our correlation analysis indicated an inverse relationship between both CPB and crossclamp time versus pulmonary vessel z scores. Further studies investigating inflection points whereupon CPB and crossclamp times are minimized, whereas maximizing attempts to spare the pulmonary valve based on pulmonary valve z scores, may be useful in directing the best surgical repair strategy. Although an iterative approach to repair that attempts to minimize pulmonary valve or right ventricle muscle resection may necessitate additional crossclamp intervals guided by physiologic data such as right ventricle pressure measurements (and therefore would not be considered technical inadequacy), our data showed that the penalization regarding increased costs were confined to those additional intervals required to address residual VSDs. Surprisingly, we found that polyethylene terephthalate VSD patch material was associated with increased POLOS. It is likely that other patch materials, such as Cormatrix, were surrogates for other favorable anatomic patient factors. Similarly, that nonautologous patch material for RVOT reconstruction was associated with increased costs is likely due to the fact that patients having synthetic material were those with antecedent palliation (ie, those with either pulmonary atresia requiring modified BlalockTausig shunt).
Patient Factors
Although not the main focus of this study, we investigated patient factors as determinants concomitant with the TPS. Such relationships are valuable in testing interactions (eg, do some patients with a given anatomy respond variably to the same operative characteristics?) and possible confounders. Genetic anomalies are well-known preoperative risk factors for less-favorable outcomes. 25 Our study was consistent with these results in that patients with trisomy 21 had increased total hospital cost. Interestingly, the total cost of care was not due to longer POLOS, possibly suggesting that the intensity or level of care required in patients with trisomy 21 is higher (ie, longer ventilation time, greater duration of sedatives, and feeding issues), but that the number of complications or duration of convalescence is equivalent. As expected, decreased weight at repair, the presence of multiple VSDs, and the presence of noncardiac anomalies were all associated with adverse outcomes.
TPS: An Imperfect Metric
The development of the TPS represents an important initial step in both quality assessment and facilitating individualized, surgeon-directed improvement. However, several authors, including our group, have elucidated limitations with the current iteration of the TPS. 5, 6 The grading system for each of these subprocedure outcomes was consensus-derived without empirically defined thresholds. Moreover, calibration and weighting were not considered because increases in subscores were assumed to be linear, and each subscore was assumed to have equal influence on the final outcome. In other words, the presence of an unintended atrial septal defect following TOF repair is weighted the same as significant RVOTO or a residual VSD despite these having variable consequence. Events conceivably within the final common pathway of adverse Refer to Table E1 for a list of all variables used in the analysis. ASD, Atrial septal defect; PA, pulmonary artery; VSD, ventricular septal defect; POLOS, postoperative length of stay; DORV, double outlet right ventricle; CPB, cardiopulmonary bypass time. *Values divided by 10,000.
outcome (eg, reintervention) were included as components of the TPS, potentially undermining attempts at correlation. Finally, the use of discharge echocardiograms, with likely unequal time components between the repair date and the echocardiogram date, introduces variability in measurement among patients. The present study does not address all of these limitations because the recently initiated Pediatric Heart Network-sponsored trial, the Residual Lesions Trial, endeavors to address many of these shortcomings. The data from that prospective multi-institutional trial will undoubtedly inform ongoing efforts at both individual-directed and specialty-directed quality improvement, and will extend the provision of value-based care.
Study Limitations
This was a single-center retrospective analysis, and therefore operative techniques varied by surgeon and postoperative care likewise varied. Lack of association between some complications and TPS may reflect a type II error. Moreover, we acknowledge that although some differences were not statistically significant (eg, cost), these differences are likely clinically relevant. Our analysis that excluded 3 outliers also suggests that some of our results could have been influenced by these particular patients. Future multiinstitutional trials may provide more clarity on this issue. However, that we were able to discern significant associations between operative factors and our primary end points (both of which were continuous) is reassuring. Although echocardiographic images were all independently reviewed using a protocol designed to capture TPS criteria, the inherent subjectivity of echocardiographic interpretation may have influenced our results. We initially aimed to establish a TPS based on intraoperative echocardiograms and correlate these with discharge echocardiograms. Unfortunately, the intraoperative images available for review inconsistently ascertained all of the TPS components needed to assign a composite score. A prospective study would be needed to develop a score that is available to surgeons in the operating room and could therefore facilitate decisions regarding the utility of intraoperative revision. Our outcomes were confined to in-hospital events, and we therefore do not have longitudinal data, which would be important in evaluating the durability of a surgical repair. However, this initial study was meant to investigate generalizability of the original TPS score, and therefore we studied outcomes that mirror those used in the initial studies.
CONCLUSIONS
The current TPS was not associated with selected postoperative TOF outcomes in our patient population, indicating that prior results may not be generalizable to all centers or surgeons. Although number of bypass runs, the duration of CPB, or the aortic crossclamp intervals are not included as components in the current TPS for TOF, they are important factors influencing both the prevalence of complications and resource use. Iterative revision to the TPS should consider the inclusion of these variables.
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If you actually look at the technical performance score categorization, insufficient or inadequate cases were categorized as 1 if there was a residual ASD.
Dr Tara B. Karamlou (Phoenix, Ariz). With regard to your first question, Christian, I think we had a larger number of repairs scored as adequate, which, for sample size reasons, had to be combined with the inadequate repairs. This could have actually diluted our ability to find certain differences between the groups. In other words, it is really a calibration issue. The differences between inadequate patients and a group of patients that includes a very large number of adequate repairs may impair the ability to find meaningful differences.
Regarding ASD, that was a univariable factor that was associated with postoperative length of stay. When we looked at it in a multivariable analysis, residual ASD did not fall out as a multivariable factor.
However, one could conceptually believe that the presence of a residual popoff may potentially decrease postoperative length of stay if it simplifies the convalescence (ie, reduction in pleural effusions). Unfortunately, when reading operative notes sometimes it is difficult to figure out when other surgeons purposely left them versus when they made them. This is among the ambiguities of any retrospective study.
Dr Pizarro. The last question I have for you relates to the fact that in this particular study, you had about I believe 10% or 15% of patients who received treatment for arrhythmias, particularly junctional ectopic tachycardia. I do not think that was obviously included in the original score.
Were you deliberately trying to just get to all the variables that might influence cost? Because in the end, it seems like it is not necessarily that you are comparing apples to apples, you know. You are adding some patientrelated intraoperative variables to that.
I wonder, how do you think that influenced your findings, because although it is a small percentage of patients, that could certainly have a significant influence on length of stay and cost.
Mr Lodin. I believe something that we worked on was including whatever variables previous literature had used in their analyses, and that definitely came up. Unfortunately, we did not see any sort of statistical significance in that association.
Personally, when doing the data collection process, we worked with whatever variables were available, whatever created some sort of variability. We had only 1 death so we couldn't do an analysis on mortality based on that, but we collected data as best as we could.
Dr Pizarro. I enjoyed your presentation. I congratulate you on this excellent work. Good job.
Readers who found these articles interesting may also like to read the following papers found in recent and future issues of our sister publications, Seminars in Thoracic and Cardiovascular Surgery and Operative Techniques in Thoracic and Cardiovascular Surgery! 
